Tidal Investments’s Avidity Biosciences RNAM Stock Holding History

Tidal Investments’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-36,440	Closed	-$2.63M	–	2544
2025 Q4	$2.63M	Buy	+36,440	New	+$2.35M	0.01%	862
2024 Q4	–	Sell	-8,871	Closed	-$407K	–	1961
2024 Q3	$407K	Buy	+8,871	New	+$385K	﹤0.01%	1472

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Tidal Investments's RNAM Position: Q1 2026 in Review

Tidal Investments sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 36,440 shares — an estimated $2.63M sold.

Tidal Investments first reported a position in RNAM in Q3 2024 and held it in 2 quarters. The position peaked at $2.63M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Tidal Investments reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Tidal Investments sold 36,440 Avidity Biosciences shares in Q1 2026, an estimated $2.63M.
Tidal Investments first reported a position in Avidity Biosciences in Q3 2024 and held it in 2 quarters.
Tidal Investments's Avidity Biosciences position peaked at $2.63M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.